Alkyl carbamate-substituted butyrolactones, process for their preparation, and pharmaceutical compositions containing them

Details for Australian Patent Application No. 2005214088 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Wolff, Maike; Wurl, Michael; Gregory, Peter-Colin; Antel, Jochen; Waldeck, Harald; Eyting, Sabine

Agent Watermark

Pub. Number AU-B-2005214088

PCT Pub. Number WO2005/080366

Priority 10 2004 009 076.9 23.02.04 DE

Filing date 18 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 9 December 2010

International Classifications

C07D 305/12 (2006.01) Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/080366 Priority application(s): WO2005/080366

9 December 2010 Application Accepted

  Published as AU-B-2005214088

7 April 2011 Standard Patent Sealed

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214090-Virus purification methods

2005214084-Imidazoline derivatives having CB1-antagonistic activity